https://grail.com/presentations/impact-of-emergency-department-ed-involvement-at-cancer-diagnosis-on-healthcare-costs-hcc-across-cancer-types-in-the-medicare-population/ 2026-05-15T20:20:59+00:00 https://grail.com/presentations/the-potential-clinical-value-of-reducing-emergency-department-ed-involvement-at-cancer-diagnosis-through-multi-cancer-early-detection-mced-testing/ 2026-05-15T20:23:30+00:00 https://grail.com/presentations/adherence-to-mammography-screening-before-and-after-receipt-of-multi-cancer-early-detection-mced-testing/ 2026-04-27T21:34:40+00:00 https://grail.com/presentations/association-between-emergency-department-ed-involvement-in-cancer-diagnosis-and-survival-across-cancer-types-in-the-medicare-population/ 2026-04-27T21:33:58+00:00 https://grail.com/presentations/performance-of-a-targeted-methylation-based-multi-cancer-early-detection-test-by-race-ethnicity-2/ 2021-06-04T13:00:40+00:00 https://grail.com/presentations/circulating-tumor-dna-ctdna-analysis-from-the-prospective-pt0-study-of-systematic-endoscopic-evaluation-see-in-patients-undergoing-radical-cystectomy-rc-for-bladder-cancer/ 2026-03-01T11:00:00+00:00 https://grail.com/presentations/biopsy-free-detection-of-residual-urothelial-carcinoma-via-cell-free-dna-methylation-in-pre-operative-urine-and-plasma/ 2025-12-06T08:20:35+00:00 https://grail.com/presentations/non-invasive-urinary-detection-of-upper-tract-urothelial-carcinoma-via-methylation-patterns-in-cell-free-dna/ 2025-12-06T11:02:24+00:00 https://grail.com/presentations/mapping-the-evidence-on-interrelationships-between-cancer-stage-financial-toxicity-ft-and-health-related-quality-of-life-hrqol/ 2026-05-12T17:53:51+00:00 https://grail.com/presentations/mental-and-behavioral-health-disorders-mbhd-among-patients-with-metastatic-and-non-metastatic-cancer-a-claims-based-analysis/ 2026-05-12T17:54:13+00:00 https://grail.com/presentations/cancer-signal-origin-cso-prediction-in-cancer-of-unknown-primary-cup-syndrome-cronus-using-circulating-tumor-dna-ctdna/ 2026-05-12T17:52:00+00:00 https://grail.com/presentations/long-term-cancer-registry-follow-up-of-false-positive-multi-cancer-early-detection-mced-test-results-from-the-symplify-study/ 2026-05-12T17:48:27+00:00 https://grail.com/presentations/reflection-real-world-evidence-study-of-multi-cancer-early-detection-mced-among-veterans-in-the-veterans-affairs-healthcare-system-presentation/ 2026-05-12T17:48:11+00:00 https://grail.com/presentations/reflection_edcc_2025/ 2026-05-12T17:48:47+00:00 https://grail.com/presentations/nhs-galleri-trial-approaches-to-retain-a-diverse-participant-cohort-across-multiple-trial-appointments/ 2026-05-12T17:49:34+00:00 https://grail.com/presentations/molecular-cancer-signal-localization-in-multi-cancer-early-detection-mced-testing-minimizes-radiation-and-imaging-burden-compared-to-whole-body-imaging-approaches/ 2026-05-12T17:49:20+00:00 https://grail.com/presentations/baseline-participant-characteristics-from-pathfinder-2-a-prospective-interventional-study-of-a-multi-cancer-early-detection-test-in-a-population-setting-2/ 2026-05-12T17:49:04+00:00 https://grail.com/presentations/safety-and-performance-of-a-multi-cancer-early-detection-mced-test-in-an-intended-use-population-initial-results-from-the-registrational-pathfinder-2-study/ 2026-05-12T17:52:16+00:00 https://grail.com/presentations/clinical-performance-of-a-blood-only-targeted-methylation-circulating-tumor-dna-ct-dna-assay-for-minimal-residual-disease-mrd-detection-in-colorectal-cancer-crd/ 2026-05-12T17:52:35+00:00 https://grail.com/presentations/baseline-participant-characteristics-from-pathfinder-2-a-prospective-interventional-study-of-a-multi-cancer-early-detection-test-in-a-population-setting/ 2025-09-20T15:15:00+00:00 https://grail.com/presentations/modelled-impact-of-a-multi-cancer-early-detection-screening-programme-on-the-demand-for-diagnostic-endoscopy-in-england/ 2025-06-25T05:10:00+00:00 https://grail.com/presentations/prognostic-significance-of-blood-based-multi-cancer-detection-in-circulating-tumor-dna-ctdna-5-year-outcomes-analysis/ 2025-05-31T07:30:00+00:00 https://grail.com/presentations/tumor-agnostic-detection-and-monitoring-of-circulating-tumor-dna-in-her2-positive-early-breast-cancer/ 2025-05-18T05:00:00+00:00 https://grail.com/presentations/is-there-value-in-knowing-perspectives-of-cancer-screening-outcomes-among-the-us-general-population/ 2025-05-16T06:00:00+00:00 https://grail.com/presentations/the-role-of-primary-care-in-addressing-inequalities-in-cancer-screening-lessons-from-enhancing-representation-of-deprived-groups-in-the-nhs-galleri-trial/ 2025-04-30T14:45:29+00:00 https://grail.com/presentations/estimated-post-test-probabilities-of-cancers-for-individuals-receiving-multi-cancer-early-detection-mced-tests/ 2025-04-30T07:00:00+00:00 https://grail.com/presentations/real-world-data-and-clinical-experience-from-over-100000-multi-cancer-early-detection-tests/ 2025-04-30T07:00:00+00:00 https://grail.com/presentations/promoter-methylation-as-a-cancer-biomarker-insights-from-ctdna-based-targeted-methylation-data/ 2025-04-28T07:00:00+00:00 https://grail.com/presentations/assessment-of-cancer-subtypes-across-multiple-cancer-types-using-a-circulating-tumor-dna-ctdna-based-targeted-methylation-assay/ 2025-04-28T07:00:00+00:00 https://grail.com/presentations/esmo-2024-retest-poster-early-real-world-experience-with-positive-multi-cancer-early-detection-mced-test-cases-and-negative-initial-diagnostic-work-up/ 2024-09-15T10:39:00+00:00 https://grail.com/presentations/detection-of-early-stage-urothelial-cancers-using-methylation-patterns-in-urine-cell-free-dna/ 2025-02-14T07:00:00+00:00 https://grail.com/presentations/comparing-changes-in-solid-component-diameter-and-mass-for-detecting-invasive-adenocarcinoma-in-sub-solid-pulmonary-nodules-ssns-the-summit-study/ 2024-12-20T16:02:02+00:00 https://grail.com/presentations/leveraging-research-informed-empathy-maps-and-personas-to-inform-the-equitable-implementation-of-multi-cancer-early-detection-tests/ 2024-12-08T11:52:58+00:00 https://grail.com/presentations/barriers-to-early-adoption-of-novel-cancer-screening-among-those-with-elevated-risk-of-cancer/ 2024-12-08T11:49:39+00:00 https://grail.com/presentations/interobserver-variability-in-cause-of-death-in-a-lung-cancer-screening-trial-a-pilot-method-study/ 2024-12-19T14:08:02+00:00 https://grail.com/presentations/recruitment-from-lung-cancer-screening-to-a-copd-clinical-trial/ 2024-12-19T14:06:55+00:00 https://grail.com/presentations/exploring-fairness-in-state-of-the-art-pulmonary-nodule-detection-algorithms/ 2024-12-16T14:19:10+00:00 https://grail.com/presentations/pulmonary-venous-quantitation-predicts-mortality-in-early-lung-fibrosis/ 2024-12-16T14:08:18+00:00 https://grail.com/presentations/stage-and-survival-of-screen-detected-small-cell-cancer-from-the-summit-study-2/ 2024-12-16T14:02:46+00:00 https://grail.com/presentations/quantification-of-breast-cancer-1-gene-brca1-promoter-methylation-in-individuals-with-and-without-cancer-using-cell-free-dna/ 2024-12-16T13:52:18+00:00 https://grail.com/presentations/cost-effectiveness-of-a-multi-cancer-early-detection-mced-test-varies-with-population-cancer-risk/ 2024-11-19T23:00:00+00:00 https://grail.com/presentations/impact-of-stage-at-cancer-diagnosis-on-total-healthcare-costs-a-national-population-based-study-using-england-individual-level-patient-data/ 2024-11-19T23:00:00+00:00 https://grail.com/presentations/applying-the-nice-disease-severity-modifier-to-the-context-of-cancer-screening/ 2024-11-19T22:45:00+00:00 https://grail.com/presentations/performance-of-a-multi-cancer-early-detection-mced-test-for-detection-of-hepatocellular-carcinoma-hcc-in-patients-with-cirrhosis-2/ 2024-11-17T13:00:00+00:00 https://grail.com/presentations/stage-at-diagnosis-and-years-of-life-lost-across-21-cancer-types-in-the-united-states/ 2024-10-23T09:00:00+00:00 https://grail.com/presentations/modelled-impact-of-a-multi-cancer-early-detection-screening-programme-on-cancer-treatment-pathways-in-england/ 2024-10-23T09:00:00+00:00 https://grail.com/presentations/reflection-initial-findings-from-a-real-world-evidence-study-of-multi-cancer-early-detection-mced-and-toxic-exposures-among-veterans-in-the-veterans-affairs-healthcare-system-va/ 2024-10-23T14:55:00+00:00 https://grail.com/presentations/multicancer-early-detection-mced/ 2024-10-16T04:31:56+00:00 https://grail.com/presentations/circulating-tumor-dna-dynamics-and-treatment-responses-in-chemotherapy-ineligible-patients-with-unresectable-stage-iii-nsclc-from-the-phase-2-duart-trial/ 2024-09-13T09:00:00+00:00 https://grail.com/presentations/circulating-tumour-dna-ctdna-clearance-with-neoadjuvant-durvalumab-d-tremelimumab-t-enfortumab-vedotin-ev-for-cisplatin-ineligible-treatment-of-muscle-invasive-bladder-cancermibc-from-th/ 2024-09-13T09:00:00+00:00 https://grail.com/presentations/cell-free-dna-indicates-potential-preclinical-detectability-of-cancer-signals-up-to-30-months-prior-to-diagnosis-2/ 2024-09-15T23:35:00+00:00 https://grail.com/presentations/modeled-economic-and-clinical-impact-of-a-multi-cancer-early-detection-mced-test-in-a-population-with-hereditary-cancer-syndromes/ 2024-09-15T03:00:00+00:00 https://grail.com/presentations/impact-of-multicancer-early-detection-mced-test-on-participant-reported-outcomes-pro-and-behavioral-intentions-by-cancer-risk/ 2024-09-15T03:00:00+00:00 https://grail.com/presentations/interstitial-lung-abnormality-presence-associates-with-mortality-in-a-lung-cancer-screening-cohort-independent-of-multi-organ-comorbidities/ 2024-09-09T03:30:00+00:00 https://grail.com/presentations/differentiating-interstitial-lung-abnormalities-and-interstitial-lung-disease-in-lung-cancer-screening/ 2024-09-09T03:30:00+00:00 https://grail.com/presentations/intention-to-have-blood-based-multi-cancer-early-detection-mced-screening-a-cross-sectional-population-based-survey-in-england-2/ 2024-06-06T08:00:00+00:00 https://grail.com/presentations/clinical-referral-to-the-nhs-following-multi-cancer-early-detection-test-results-from-the-nhs-galleri-trial/ 2024-06-04T01:30:00+00:00 https://grail.com/presentations/positive-mced-test-results-associated-with-subsequent-cancer-diagnosis-in-participants-in-the-symplify-study/ 2024-06-04T01:30:00+00:00 https://grail.com/presentations/enhancing-the-diagnostic-performance-of-a-multi-cancer-early-detection-test-with-patient-characteristics-symptoms-and-standard-laboratory-test-results/ 2024-06-04T01:30:00+00:00 https://grail.com/presentations/impact-of-negative-cancer-screening-results-on-patient-reported-outcomes-and-behavioral-intentions/ 2024-06-03T23:30:00+00:00 https://grail.com/presentations/diagnostic-test-use-and-time-to-cancer-diagnosis-in-medicare-recipients/ 2024-06-01T07:05:55+00:00 https://grail.com/presentations/multi-cancer-early-detection-mced-test-performance-in-cancer-survivors/ 2024-06-01T07:05:00+00:00 https://grail.com/presentations/performance-of-volume-and-diameter-thresholds-in-predicting-and-excluding-malignancy-in-screen-detected-solid-nodules-in-the-summit-study/ 2023-11-22T07:32:51+00:00 https://grail.com/presentations/respiratory-symptoms-present-when-assessed-for-the-summit-study-a-lung-cancer-screening-study/ 2024-05-20T10:15:00+00:00 https://grail.com/presentations/the-completion-and-concordance-of-cancer-data-collected-on-site-and-from-central-registries-in-england-and-wales/ 2024-05-10T10:46:23+00:00 https://grail.com/presentations/utility-of-pet-ct-for-nodal-staging-in-a-lung-cancer-screening-cohort/ 2024-04-18T08:06:02+00:00 https://grail.com/presentations/stage-and-survival-of-screen-detected-small-cell-cancer-from-the-summit-study/ 2024-04-18T08:05:57+00:00 https://grail.com/presentations/utility-of-pet-ct-for-nodule-discrimination-in-the-summit-study/ 2024-04-18T08:05:52+00:00 https://grail.com/presentations/assessing-the-additional-value-of-negative-multi-cancer-early-detection-mced-tests-results-from-an-online-survey-of-the-general-population/ 2024-05-07T12:30:00+00:00 https://grail.com/presentations/an-overview-of-methods-employed-in-economic-models-of-cancer-screening-tests-a-systematic-literature-review-slr/ 2024-05-07T12:30:00+00:00 https://grail.com/presentations/analyses-of-cancer-prevalence-and-healthcare-costs-for-metastatic-and-non-metastatic-cancers-among-employees-using-claims-data/ 2024-05-06T12:30:00+00:00 https://grail.com/presentations/economic-evaluations-of-cancer-screening-tests-in-the-us-a-systematic-literature-review-slr/ 2024-05-06T12:30:00+00:00 https://grail.com/presentations/the-impact-of-routine-cancer-screening-on-disparities-in-cancer-diagnosis-stages-among-socioeconomic-populations/ 2024-04-16T09:00:00+00:00 https://grail.com/presentations/working-and-cancer-the-impact-of-cancer-diagnosis-and-treatment-on-employment-presenteeism-and-productivity/ 2024-04-05T07:30:00+00:00 https://grail.com/presentations/early-real-world-experience-with-repeat-multi-cancer-early-detection-mced-testing/ 2024-04-08T14:30:00+00:00 https://grail.com/presentations/identification-of-cancer-subtypes-with-a-ctdna-based-targeted-methylation-assay/ 2024-04-10T09:00:00+00:00 https://grail.com/presentations/most-cancer-deaths-are-unaddressed-by-current-screening-paradigms/ 2024-04-09T13:30:00+00:00 https://grail.com/presentations/athfinder-2-a-prospective-study-to-evaluate-safety-and-performance-of-a-multi-cancer-early-detection-test-in-a-population-setting/ 2024-04-09T09:00:00+00:00 https://grail.com/presentations/prognostic-significance-of-blood-based-multi-cancer-detection-in-cell-free-dna-4-year-outcomes-analysis/ 2024-04-08T14:30:00+00:00 https://grail.com/presentations/a-targeted-methylation-based-mced-blood-test-preferentially-detects-high-grade-prostate-cancer-and-minimizes-overdiagnosis/ 2024-04-07T09:50:26+00:00 https://grail.com/presentations/acceptability-of-multi-cancer-early-detection-mced-blood-tests-as-a-population-based-screening-programme-a-qualitative-study-in-great-britain-2/ 2024-03-25T08:07:15+00:00 https://grail.com/presentations/intention-to-have-blood-based-multi-cancer-early-detection-mced-screening-a-cross-sectional-population-based-survey-in-england/ 2024-03-25T08:05:24+00:00 https://grail.com/presentations/cfdna-methylation-based-pan-hematologic-prognostic-classification/ 2023-12-11T18:00:00+00:00 https://grail.com/presentations/methylation-biology-of-a-blood-based-mds-risk-stratification-test/ 2023-12-11T18:00:00+00:00 https://grail.com/presentations/multi-cancer-early-detection-test-is-sensitive-and-accurate-in-detecting-shared-dna-methylation-signal-in-a-variety-of-lymphoid-and-plasma-cell-neoplasms/ 2023-12-10T18:00:00+00:00 https://grail.com/presentations/detection-and-quantification-of-triple-negative-breast-cancer-across-ethnicities-through-analysis-of-cell-free-dna-methylation/ 2023-12-08T10:00:00+00:00 https://grail.com/presentations/analytical-performance-of-a-cell-free-dna-targeted-methylation-test-for-early-lung-adenocarcinoma-luad-recurrence-prediction/ 2023-12-02T15:40:00+00:00 https://grail.com/presentations/the-summit-study-four-week-quit-rates-amongst-individuals-referred-to-stop-smoking-services-following-attendance-at-a-lung-health-check/ 2023-11-29T14:48:47+00:00 https://grail.com/presentations/cost-effectiveness-of-multicancer-early-detection-mced-with-preferential-detection-of-clinically-aggressive-cancers/ 2023-11-14T08:30:00+00:00 https://grail.com/presentations/symptom-burden-and-health-related-quality-of-life-in-gastrointestinal-cancers-a-targeted-literature-review/ 2023-11-13T08:30:00+00:00 https://grail.com/presentations/performance-of-a-multi-cancer-early-detection-mced-test-for-detection-of-hepatocellular-carcinoma-hcc-in-patients-with-cirrhosis/ 2023-11-13T06:00:00+00:00 https://grail.com/presentations/burden-of-liver-cancer-among-medicaid-insured-patients-a-retrospective-analysis-of-a-national-all-payer-claims-database/ 2023-10-24T10:30:00+00:00 https://grail.com/presentations/performance-of-colon-and-rectal-cancer-detection-with-a-multi-cancer-early-detection-mced-blood-test/ 2023-10-22T15:30:00+00:00 https://grail.com/presentations/detection-of-gastrointestinal-cancer-in-individuals-without-clinical-suspicion-of-cancer-using-a-multi-cancer-early-detection-test-in-the-pathfinder-study/ 2023-10-22T15:30:00+00:00 https://grail.com/presentations/nhs-galleri-trial-enrolment-approaches-and-participant-sociodemographic-characteristics/ 2023-10-22T03:00:00+00:00 https://grail.com/presentations/cancer-incidence-in-the-medicaid-population-a-retrospective-analysis-of-a-national-all-payer-claims-database/ 2023-10-18T08:00:00+00:00 https://grail.com/presentations/acceptability-of-multi-cancer-early-detection-mced-blood-tests-as-a-population-based-screening-programme-a-qualitative-study-in-great-britain/ 2023-10-11T00:45:00+00:00 https://grail.com/presentations/leveling-the-playing-field-when-comparing-multi-cancer-early-detection-mced-tests-weighting-by-cancer-type-and-stage/ 2023-10-11T00:45:00+00:00 https://grail.com/presentations/the-impact-of-screening-participation-on-modelled-mortality-benefits-of-a-multi-cancer-early-detection-test-by-socioeconomic-group-in-england/ 2023-10-10T01:00:00+00:00 https://grail.com/presentations/employer-based-implementation-of-galleri-multi-cancer-early-detection-testing-to-address-socioeconomic-disparities-in-receipt-of-screening/ 2023-10-01T15:00:00+00:00 https://grail.com/presentations/robustness-of-a-targeted-methylation-based-multi-cancer-early-detection-mced-test-to-population-differences-in-self-reported-ethnicity/ 2023-10-01T15:00:00+00:00 https://grail.com/presentations/growth-patterns-of-screen-detected-malignant-pulmonary-nodules-accuracy-of-doubling-time-models/ 2023-09-11T08:58:54+00:00 https://grail.com/presentations/generalizing-and-transporting-diagnostic-test-performance-to-a-target-population/ 2023-08-08T11:00:09+00:00 https://grail.com/presentations/overall-and-non-lung-cancer-incidence-in-the-national-lung-screening-trial-as-indicators-of-potential-for-multi-cancer-screening/ 2023-06-23T04:00:39+00:00 https://grail.com/presentations/nhs-galleri-trial-of-multi-cancer-early-detection-design-and-equitable-study-recruitment-tactics/ 2023-06-22T04:00:24+00:00 https://grail.com/presentations/dynamic-data-enabled-stratified-sampling-for-cancer-screening-trial-invitations-with-application-in-nhs-galleri/ 2023-06-22T04:00:02+00:00 https://grail.com/presentations/methylated-dna-biomarkers-and-incident-cancer-in-the-american-cancer-society-acs-cancer-prevention-study-3-cps-3-cohort/ 2023-06-06T11:00:44+00:00 https://grail.com/presentations/large-scale-observational-prospective-cohort-study-of-a-multi-cancer-early-detection-mced-test-in-symptomatic-patients-referred-for-cancer-investigation/ 2023-06-06T11:00:09+00:00 https://grail.com/presentations/preclinical-circulating-tumor-dna-ctdna-shedding-duration-and-prognostic-implications-of-modeling-3669-participants-from-american-cancer-society-cancer-prevention-study-3-cps-3-and-circulating-cel/ 2023-06-06T11:00:31+00:00 https://grail.com/presentations/overall-and-non-lung-cancer-incidence-in-the-national-lung-screening-trial-nlst-as-indicators-of-potential-for-multi-cancer-screening/ 2023-06-06T11:00:54+00:00 https://grail.com/presentations/examining-the-potential-for-lead-time-bias-by-estimating-stage-specific-proportions-of-deaths-due-to-diagnosed-cancer/ 2023-06-06T11:00:46+00:00 https://grail.com/presentations/methylation-based-prediction-of-myelodysplastic-syndrome-survival-outcomes/ 2023-06-06T11:00:37+00:00 https://grail.com/presentations/elevated-cancer-risk-among-individuals-with-combinations-of-cancer-related-risk-factors-a-large-claims-database-analysis/ 2023-06-06T11:00:43+00:00 https://grail.com/presentations/implementation-of-a-multi-cancer-early-detection-test-using-a-centralized-model-within-a-multi-state-health-system/ 2023-06-06T11:00:38+00:00 https://grail.com/presentations/early-real-world-experience-with-a-multi-cancer-early-detection-test/ 2023-06-06T11:00:30+00:00 https://grail.com/presentations/clinical-evaluation-of-cancer-signal-origin-cso-prediction-and-diagnostic-resolution-following-multi-cancer-early-detection-testing/ 2023-06-06T11:00:35+00:00 https://grail.com/presentations/the-value-of-no-cancer-signal-detected-results-from-multi-cancer-early-detection-tests-perspectives-of-people-in-the-general-population/ 2023-05-10T06:00:58+00:00 https://grail.com/presentations/us-population-at-elevated-risk-for-cancer-population-size-and-characteristics/ 2023-05-10T06:00:07+00:00 https://grail.com/presentations/the-potential-effect-of-future-medical-cost-changes-on-the-net-cost-of-multi-cancer-early-detection-testing/ 2023-05-10T06:00:06+00:00 https://grail.com/presentations/utility-of-ctdna-based-targeted-methylation-mrd-assay-for-hematological-malignancies/ 2023-04-17T15:51:42+00:00 https://grail.com/presentations/patient-characteristics-diagnostic-journey-and-cancer-enrichment-among-patients-with-nonspecific-signs-and-or-symptoms-in-the-us-community-oncology-setting-a-real-world-retrospective-study/ 2023-04-19T06:00:29+00:00 https://grail.com/presentations/analytical-validation-of-a-tissue-free-multi-cancer-post-diagnosis-cancer-research-test-that-uses-cell-free-dna-methylation-profiling/ 2023-04-19T06:00:41+00:00 https://grail.com/presentations/a-case-of-stage-i-hpv-mediated-oropharyngeal-squamous-cell-carcinoma-detected-using-a-multi-cancer-early-detection-test/ 2023-04-19T06:00:37+00:00 https://grail.com/presentations/a-case-of-stage-iia-anal-squamous-cell-carcinoma-detected-using-a-multi-cancer-early-detection-test/ 2023-04-19T06:00:37+00:00 https://grail.com/presentations/clonal-b-cell-expansion-and-the-potential-challenges-to-blood-based-early-cancer-detection/ 2023-04-16T10:30:38+00:00 https://grail.com/presentations/psychological-impact-of-the-galleri-test-signal-protocol-for-a-longitudinal-evaluation-of-the-psychological-impact-of-receiving-a-cancer-signal-in-the-nhs-galleri-trial/ 2023-03-24T09:47:19+00:00 https://grail.com/presentations/the-potential-clinical-impact-of-a-multi-cancer-early-detection-test-for-individuals-with-missing-cancer-stage-information/ 2023-03-31T04:30:52+00:00 https://grail.com/presentations/extensive-and-dynamic-signs-and-symptoms-prior-to-cancer-diagnoses/ 2023-03-31T04:30:17+00:00 https://grail.com/presentations/population-health-impact-of-incorporating-a-multi-cancer-early-detection-mced-test-to-existing-cancer-screening-among-immunocompromised-individuals/ 2023-03-23T09:30:56+00:00 https://grail.com/presentations/urine-cell-free-dna-improves-detection-of-bladder-cancer-compared-to-blood-based-screening/ 2023-02-17T12:30:34+00:00 https://grail.com/presentations/a-case-of-stage-ii-hepatocellular-carcinoma-diagnosed-using-a-multi-cancer-early-detection-test/ 2022-11-18T17:00:06+00:00 https://grail.com/presentations/a-case-of-stage-i-esophageal-adenocarcinoma-diagnosed-using-a-multi-cancer-early-detection-test/ 2022-11-18T17:00:58+00:00 https://grail.com/presentations/cancer-survivorship-surveillance-patterns-among-earlier-staged-lung-cancer-lc-patients/ 2022-11-07T01:00:42+00:00 https://grail.com/presentations/cost-effectiveness-of-multi-cancer-early-detection-mced-testing-using-mixture-cure-modeling-mcm/ 2022-11-07T01:00:12+00:00 https://grail.com/presentations/the-burden-of-cancer-among-enrollees-insured-through-commercial-plans-in-the-us-2019-2020/ 2022-11-09T00:00:02+00:00 https://grail.com/presentations/cost-effectiveness-of-multi-cancer-early-detection-mced-test-in-subgroups-with-smoking-history-or-obesity-2/ 2022-11-04T12:30:26+00:00 https://grail.com/presentations/time-to-diagnosis-among-patients-with-cancer-in-the-us-2/ 2022-11-04T12:30:57+00:00 https://grail.com/presentations/a-prospective-study-of-a-multi-cancer-early-detection-blood-test-in-a-clinical-practice-setting-2/ 2022-10-15T07:10:06+00:00 https://grail.com/presentations/modeled-comparison-of-population-blood-based-cancer-screening-approaches-multiple-single-cancer-early-detection-tests-vs-one-multi-cancer-early-detection-test/ 2022-10-18T17:00:41+00:00 https://grail.com/presentations/shared-cancer-signal-evidence-from-cross-training-2/ 2022-10-18T17:00:32+00:00 https://grail.com/presentations/a-prospective-study-of-a-multi-cancer-early-detection-blood-test-in-a-clinical-practice-setting/ 2022-10-18T17:00:28+00:00 https://grail.com/presentations/evaluation-of-anxiety-distress-and-satisfaction-using-a-multi-cancer-early-detection-mced-test/ 2022-10-18T17:00:21+00:00 https://grail.com/presentations/estimating-the-incremental-population-health-impact-of-a-multi-cancer-early-detection-test-to-complement-existing-screening-among-populations-with-an-elevated-risk-for-cancer-with-additional-risk-fact/ 2022-10-14T08:15:47+00:00 https://grail.com/presentations/out-of-pocket-costs-by-cancer-stage-among-medicare-advantage-insured-patients-2016-2020/ 2022-10-14T08:15:52+00:00 https://grail.com/presentations/cost-effectiveness-of-a-multi-cancer-early-detection-mced-test-in-individuals-with-a-personal-or-family-history-of-cancer/ 2022-10-14T08:15:59+00:00 https://grail.com/presentations/pathfinder-a-prospective-study-of-a-multi-cancer-early-detection-blood-test/ 2022-09-11T07:00:10+00:00 https://grail.com/presentations/time-to-diagnosis-among-patients-with-cancer-in-the-us/ 2022-09-12T07:40:48+00:00 https://grail.com/presentations/evaluation-of-anxiety-distress-and-satisfaction-with-a-multi-cancer-early-detection-test/ 2022-09-10T23:30:28+00:00 https://grail.com/presentations/prediction-of-the-risk-of-recurrence-in-patients-with-non-small-cell-lung-cancer-using-an-integrated-claims-and-electronic-medical-record-database/ 2022-09-11T23:30:23+00:00 https://grail.com/presentations/prevalence-and-demographics-of-marijuana-users-in-a-lung-cancer-screening-cohort/ 2022-09-04T01:06:55+00:00 https://grail.com/presentations/clinical-insights-from-use-of-a-blood-based-multi-cancer-early-detection-test/ 2022-09-20T06:00:23+00:00 https://grail.com/presentations/is-cancer-diagnosis-in-the-us-timely-an-assessment-of-the-time-to-diagnosis-among-patients-diagnosed-with-cancer/ 2022-09-20T06:00:38+00:00 https://grail.com/presentations/costs-and-benefits-of-a-multi-cancer-early-detection-test-in-a-medicare-population/ 2022-09-20T06:00:11+00:00 https://grail.com/presentations/targeted-methylation-analysis-of-circulating-cell-free-dna-to-predict-outcomes-in-clinical-stage-i-nsclc-patients/ 2022-08-07T00:45:21+00:00 https://grail.com/presentations/the-aggregate-value-of-existing-cancer-screenings-in-the-us/ 2022-06-05T11:15:08+00:00 https://grail.com/presentations/social-costs-of-cancer/ 2022-06-05T11:15:02+00:00 https://grail.com/presentations/nhs-galleri-trial-design-equitable-study-recruitment-tactics-for-targeted-population-level-screening-with-a-multi-cancer-early-detection-mced-test/ 2022-06-06T11:15:48+00:00 https://grail.com/presentations/shared-cancer-signal-evidence-from-cross-training/ 2022-05-19T16:40:02+00:00 https://grail.com/presentations/time-trend-of-incidence-rates-in-cancers-with-and-without-commonly-adopted-guideline-recommended-screening-cgrs-in-the-us-2000-2018/ 2022-05-18T06:00:43+00:00 https://grail.com/presentations/employment-decrease-among-patients-newly-diagnosed-with-early-versus-late-stage-cancers-in-the-u-s/ 2022-05-17T09:15:04+00:00 https://grail.com/presentations/increasing-out-of-pocket-costs-by-stage-among-commercially-insured-patients-diagnosed-with-cancer-2016-2020/ 2022-05-16T02:30:45+00:00 https://grail.com/presentations/assessment-of-health-state-utilities-associated-with-false-positive-cancer-screening-results/ 2022-05-16T02:30:37+00:00 https://grail.com/presentations/assessment-of-value-based-price-vbp-for-a-multi-cancer-early-detection-mced-test-in-a-medicare-population/ 2022-05-16T09:15:54+00:00 https://grail.com/presentations/specific-and-differential-detection-of-breast-and-lung-cancer-via-cell-free-rna/ 2022-05-10T06:00:24+00:00 https://grail.com/presentations/diagnostic-journey-following-a-multi-cancer-early-detection-test-a-retrospective-case-series-of-gastrointestinal-cancers-in-the-pathfinder-study/ 2022-04-08T10:00:33+00:00 https://grail.com/presentations/detecting-cancer-when-it-can-be-cured-the-potential-for-cure-across-all-stageable-cancers/ 2022-04-08T10:00:47+00:00 https://grail.com/presentations/identifying-populations-at-elevated-risk-of-cancer-outside-those-traditionally-targeted-for-screening-and-prevention/ 2022-04-08T10:00:35+00:00 https://grail.com/presentations/productivity-loss-associated-with-late-versus-early-stage-cancer-diagnosis/ 2022-03-31T04:30:45+00:00 https://grail.com/presentations/patient-preferences-for-multi-cancer-early-detection-tests-a-discrete-choice-experiment-dce/ 2022-03-31T04:30:50+00:00 https://grail.com/presentations/cost-effectiveness-of-multi-cancer-early-detection-mced-test-in-subgroups-with-smoking-history-or-obesity/ 2022-03-31T04:30:05+00:00 https://grail.com/presentations/cancer-incidence-in-immunocompromised-patients/ 2022-03-31T04:30:39+00:00 https://grail.com/presentations/drivers-of-value-based-pricing-vbp-for-a-multi-cancer-early-detection-mced-test-2/ 2022-03-30T14:00:02+00:00 https://grail.com/presentations/pilot-study-for-assessment-of-health-state-utilities-associated-with-false-positive-cancer-screening-results-2/ 2022-03-30T14:00:26+00:00 https://grail.com/presentations/quality-assurance-of-radiology-reporting-in-lung-cancer-screening-the-role-of-a-radiology-review-meeting/ 2022-01-28T19:33:34+00:00 https://grail.com/presentations/expanding-the-way-we-screen-for-cancer-a-path-to-a-multi-cancer-early-detection-test-3/ 2021-11-21T21:39:32+00:00 https://grail.com/presentations/a-prespecified-interim-analysis-of-the-pathfinder-study-performance-of-a-multi%e2%80%90cancer-early-detection-test-in-support-of-clinical-implementation/ 2021-06-08T21:35:38+00:00 https://grail.com/presentations/interim-results-of-pathfinder-a-clinical-use-study-using-a-methylation-based-multi-cancer-early-detection-test/ 2021-06-04T21:35:33+00:00 https://grail.com/presentations/drivers-of-value-based-pricing-vbp-for-a-multi-cancer-early-detection-mced-test/ 2021-11-30T05:00:49+00:00 https://grail.com/presentations/pilot-study-for-assessment-of-health-state-utilities-associated-with-false-positive-cancer-screening-results/ 2021-11-30T05:00:26+00:00 https://grail.com/presentations/patient-preferences-for-attributes-of-a-multi-cancer-early-detection-test-a-discrete-choice-experiment-dce-quantitative-pilot-study/ 2021-11-30T05:00:43+00:00 https://grail.com/presentations/impact-of-the-covid-19-pandemic-on-health-services-utilisation-in-a-lung-cancer-screening-cohort/ 2021-11-24T05:00:31+00:00 https://grail.com/presentations/performance-of-a-multi-cancer-detection-test-as-a-tool-for-diagnostic-resolution-of-symptomatic-gynecological-cancers/ 2021-11-16T09:46:15+00:00 https://grail.com/presentations/expanding-the-way-we-screen-for-cancer-a-path-to-a-multi-cancer-early-detection-test-2/ 2026-05-12T17:50:48+00:00 https://grail.com/presentations/detecting-cancer-signal-across-multiple-cancers-with-one-blood-draw-validating-a-multi-cancer-early-detection-mced-test/ 2021-09-28T16:38:44+00:00 https://grail.com/presentations/reflection-observational-study-to-evaluate-real-world-performance-of-the-galleri-blood-based-multi-cancer-early-detection-test-in-clinical-settings/ 2021-09-28T16:37:36+00:00 https://grail.com/presentations/multi-cancer-detection-test-to-aid-clinically-presenting-head-and-neck-cancer-diagnosis/ 2021-10-03T16:35:09+00:00 https://grail.com/presentations/expanding-the-way-we-screen-for-cancer-a-path-to-a-multi-cancer-early-detection-test/ 2021-09-28T16:33:53+00:00 https://grail.com/presentations/multi-cancer-early-detection-test-sensitivity-for-cancers-with-and-without-current-population-level-screening-options/ 2021-10-29T13:00:09+00:00 https://grail.com/presentations/the-patient-journey-prior-to-cancer-diagnosis-a-cross-sectional-observational-study-of-provider-type-encounters-prior-to-cancer-diagnosis/ 2021-10-20T18:00:29+00:00 https://grail.com/presentations/increasing-healthcare-costs-by-stage-and-over-time-among-patients-diagnosed-with-cancer-2008-2020/ 2021-10-20T18:00:33+00:00 https://grail.com/presentations/adherence-to-breast-colorectal-lung-prostate-and-cervical-cancer-screening-guidelines-in-a-large-commercial-and-medicare-advantage-plan/ 2021-10-20T18:00:19+00:00 https://grail.com/presentations/impact-of-mced-screening-interval-on-reduction-in-late-stage-cancer-diagnosis-and-mortality/ 2021-09-17T17:12:33+00:00 https://grail.com/presentations/the-summit-study-quality-of-spirometry-performed-as-part-of-a-lung-health-check-lhc-assessment-for-inclusion-into-low-dose-computed-tomography-ldct-lung-cancer-screening-lcs/ 2021-05-10T21:32:53+00:00 https://grail.com/presentations/the-summit-study-pulmonary-nodule-and-incidental-findings-in-the-first-10000-participants-of-a-population-based-low-dose-ct-screening-study/ 2021-01-10T21:28:09+00:00 https://grail.com/presentations/stage-shift-by-screening-with-a-multi-cancer-early-detection-test-microsimulation-modeling-to-inform-the-design-of-a-pragmatic-randomized-controlled-trial/ 2021-08-25T21:24:32+00:00 https://grail.com/presentations/prognostic-significance-of-blood-based-multi-cancer-detection-in-plasma-cell-free-dna-2/ 2021-09-20T16:46:58+00:00 https://grail.com/presentations/detection-of-cancer-signal-for-over-50-ajcc-cancer-types-with-a-multi-cancer-early-detection-test/ 2021-06-04T13:00:24+00:00 https://grail.com/presentations/performance-of-a-targeted-methylation-based-multi-cancer-early-detection-test-by-race-ethnicity/ 2021-06-04T13:00:40+00:00 https://grail.com/presentations/reductions-in-cancer-screening-the-consequence-of-changes-in-routine-care-during-the-covid-19-pandemic/ 2021-06-04T13:00:56+00:00 https://grail.com/presentations/analytical-validation-of-a-multi-cancer-early-detection-test-with-tissue-localization-using-a-cell-free-dna-based-targeted-methylation-assay/ 2020-06-24T19:01:55+00:00